Home / News and media / Stock exchange releases / Archive / 2007

2007

Nov 27th 2007 6:20 PM Stock Exchange Release

Announcement by Orion Corporation in accordance with section 10 of chapter 2 of the Finnish Securities Market Act
Nov 15th 2007 1:00 PM Stock Exchange Release

Appointments into Orion's Executive Management Board as of 1 January 2008
Nov 13th 2007 7:37 PM Stock Exchange Release

Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for Stalevo®
Oct 24th 2007 5:35 PM Stock Exchange Release

Composition of the Nomination Committee of Orion Corporation
Oct 24th 2007 11:08 AM Stock Exchange Release

Orion Corporation's publication schedules for financial reporting in 2008
Oct 24th 2007 10:59 AM Stock Exchange Release

Orion Group Interim Report 1-9/2007
Oct 1st 2007 6:27 PM Stock Exchange Release

Orion comments on ANDA filing of generic versions of Orion's proprietary drug Stalevo® in the United States
Sep 13th 2007 8:16 PM Stock Exchange Release

Orion sues generic drug companies in the U.S. to enforce patents for entacapone (Orion's proprietary drug Comtan®)
Sep 11th 2007 3:01 PM Stock Exchange Release

New President and CEO for Orion Corporation as of 1 January 2008
Aug 13th 2007 6:18 PM Stock Exchange Release

Orion comments on ANDA filing of generic entacapone (Orion's proprietary drug Comtan®) in the United States
Aug 6th 2007 11:20 AM Stock Exchange Release

Decision of the Board of Directors of Orion on repurchasing own shares
Aug 6th 2007 10:55 AM Stock Exchange Release

Orion Group Interim Report 1-6/2007
Apr 25th 2007 11:05 AM Stock Exchange Release

Orion Group Interim Report 1-3/2007
Apr 25th 2007 9:55 AM Stock Exchange Release

Orion's partner discontinues development of levosimendan (Simdax) in the US
Apr 2nd 2007 8:30 PM Stock Exchange Release

Jukka Ylppö Vice Chairman of the Board of Directors of Orion Corporation. Compositions of Board committees
Apr 2nd 2007 8:00 PM Stock Exchange Release

Decisions by the AGM of Orion Corporation on 2 April 2007
Mar 8th 2007 3:04 PM Stock Exchange Release

Amendment to the Annual Report 2006 of Orion Corporation concerning holdings of Board members
Mar 1st 2007 3:34 PM Stock Exchange Release

Orion Group Annual Report 2006 published
Feb 6th 2007 1:15 PM Stock Exchange Release

Matters to be handled at Orion's AGM on 2 April 2007
Feb 6th 2007 12:22 PM Stock Exchange Release

Orion updates progress with Simdax (i.v. levosimendan):
Feb 6th 2007 12:17 PM Stock Exchange Release

Orion Group Financial Review (proforma) 1-12/2006
Feb 6th 2007 12:13 PM Stock Exchange Release

Bulletin of Orion Corporation Financial Statements for 1 July - 31 December 2006
Jan 29th 2007 6:10 PM Stock Exchange Release

Recommendation by the Nomination Committee concerning Board of Directors to be elected by the AGM of Orion Corporation
Jan 24th 2007 4:06 PM Stock Exchange Release

Share-based incentive plan for ca. 30 key persons in Orion
Jan 24th 2007 3:54 PM Stock Exchange Release

Change in the Executive Management Board of the Orion Group as of 1 February 2007

2007

Announcement by Orion Corporation in accordance with section 10 of chapter 2 of the Finnish Securities Market Act

Appointments into Orion's Executive Management Board as of 1 January 2008

Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for Stalevo®

Composition of the Nomination Committee of Orion Corporation

Orion Corporation's publication schedules for financial reporting in 2008

Orion Group Interim Report 1-9/2007

Orion comments on ANDA filing of generic versions of Orion's proprietary drug Stalevo® in the United States

Orion sues generic drug companies in the U.S. to enforce patents for entacapone (Orion's proprietary drug Comtan®)

New President and CEO for Orion Corporation as of 1 January 2008

Orion comments on ANDA filing of generic entacapone (Orion's proprietary drug Comtan®) in the United States

Decision of the Board of Directors of Orion on repurchasing own shares

Orion Group Interim Report 1-6/2007

Orion Group Interim Report 1-3/2007

Orion's partner discontinues development of levosimendan (Simdax) in the US

Jukka Ylppö Vice Chairman of the Board of Directors of Orion Corporation. Compositions of Board committees

Decisions by the AGM of Orion Corporation on 2 April 2007

Amendment to the Annual Report 2006 of Orion Corporation concerning holdings of Board members

Orion Group Annual Report 2006 published

Matters to be handled at Orion's AGM on 2 April 2007

Orion updates progress with Simdax (i.v. levosimendan):

Orion Group Financial Review (proforma) 1-12/2006

Bulletin of Orion Corporation Financial Statements for 1 July - 31 December 2006

Recommendation by the Nomination Committee concerning Board of Directors to be elected by the AGM of Orion Corporation

Share-based incentive plan for ca. 30 key persons in Orion

Change in the Executive Management Board of the Orion Group as of 1 February 2007

Archive

2012

2011

2010

2009

2008

2007

2006